Clinton Bybee - Net Worth and Insider Trading
Clinton Bybee Net Worth
The estimated net worth of Clinton Bybee is at least $283 Million dollars as of 2024-08-27. Clinton Bybee is the Director of Impinj Inc and owns about 1,371,152 shares of Impinj Inc (PI) stock worth over $223 Million. Clinton Bybee is also the 10% Owner of Alnylam Pharmaceuticals Inc and owns about 222,500 shares of Alnylam Pharmaceuticals Inc (ALNY) stock worth over $60 Million. Details can be seen in Clinton Bybee's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Clinton Bybee has not made any transactions after 2017-11-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Clinton Bybee
Clinton Bybee Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Clinton Bybee owns 34 companies in total, including Codiak BioSciences Inc (CDAKQ) , Metacrine Inc (MTCR) , and Impinj Inc (PI) among others .
Click here to see the complete history of Clinton Bybee’s form 4 insider trades.
Insider Ownership Summary of Clinton Bybee
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CDAKQ | Codiak BioSciences Inc | 2020-10-13 | 10 percent owner |
MTCR | Metacrine Inc | 2020-09-15 | 10 percent owner |
PI | Impinj Inc | 2017-11-09 | director |
![]() | ![]() | 2020-02-05 | 10 percent owner |
![]() | ![]() | 2021-03-30 | 10 percent owner |
![]() | ![]() | 2019-08-08 | 10 percent owner |
![]() | ![]() | 2019-03-07 | 10 percent owner |
![]() | ![]() | 2019-06-27 | 10 percent owner |
![]() | ![]() | 2018-03-27 | 10 percent owner |
![]() | ![]() | 2019-02-22 | 10 percent owner |
![]() | ![]() | 2019-02-07 | 10 percent owner |
![]() | ![]() | 2018-11-02 | 10 percent owner |
![]() | ![]() | 2018-05-23 | 10 percent owner |
![]() | ![]() | 2018-05-02 | 10 percent owner |
![]() | ![]() | 2018-04-03 | other: Former 10% owner |
![]() | ![]() | 2020-11-20 | 10 percent owner |
![]() | ![]() | 2016-10-11 | director & 10 percent owner |
![]() | ![]() | 2016-05-23 | 10 percent owner |
![]() | ![]() | 2016-03-15 | 10 percent owner |
![]() | ![]() | 2015-10-30 | 10 percent owner |
![]() | ![]() | 2015-01-14 | 10 percent owner |
![]() | ![]() | 2014-06-23 | 10 percent owner |
![]() | ![]() | 2015-02-13 | 10 percent owner |
![]() | ![]() | 2014-03-17 | 10 percent owner |
![]() | ![]() | 2013-09-30 | 10 percent owner |
![]() | ![]() | 2013-06-18 | 10 percent owner |
![]() | ![]() | 2011-07-21 | 10 percent owner |
![]() | ![]() | 2004-03-10 | 10 percent owner |
![]() | ![]() | 2004-05-27 | 10 percent owner |
![]() | ![]() | 2003-11-26 | 10 percent owner |
![]() | ![]() | 2020-12-17 | 10 percent owner |
![]() | ![]() | 2021-02-03 | 10 percent owner |
![]() | ![]() | 2021-06-16 | 10 percent owner |
![]() | ![]() | 2023-09-14 | 10 percent owner |
Clinton Bybee Latest Holdings Summary
Clinton Bybee currently owns a total of 2 stocks. Among these stocks, Clinton Bybee owns 1,371,152 shares of Impinj Inc (PI) as of November 9, 2017, with a value of $223 Million and a weighting of 78.82%. Clinton Bybee also owns 222,500 shares of Alnylam Pharmaceuticals Inc (ALNY) as of May 27, 2004, with a value of $60 Million and a weighting of 21.18%.
Latest Holdings of Clinton Bybee
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
PI | Impinj Inc | 2017-11-09 | 1,371,152 | 162.50 | 222,812,200 |
ALNY | Alnylam Pharmaceuticals Inc | 2004-05-27 | 222,500 | 269.07 | 59,868,075 |
Holding Weightings of Clinton Bybee
Clinton Bybee Form 4 Trading Tracker
According to the SEC Form 4 filings, Clinton Bybee has made a total of 0 transactions in Impinj Inc (PI) over the past 5 years. The most-recent trade in Impinj Inc is the acquisition of 4,000 shares on November 9, 2017, which cost Clinton Bybee around $97,720.
According to the SEC Form 4 filings, Clinton Bybee has made a total of 0 transactions in Alnylam Pharmaceuticals Inc (ALNY) over the past 5 years. The most-recent trade in Alnylam Pharmaceuticals Inc is the sale of 0 shares on May 27, 2004, which brought Clinton Bybee around $0.
Insider Trading History of Clinton Bybee
- 1
Clinton Bybee Trading Performance
GuruFocus tracks the stock performance after each of Clinton Bybee's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Clinton Bybee is -51.02%. GuruFocus also compares Clinton Bybee's trading performance to market benchmark return within the same time period. The performance of stocks bought by Clinton Bybee within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Clinton Bybee's insider trading performs compared to the benchmark.
Performance of Clinton Bybee
Clinton Bybee Ownership Network
Ownership Network List of Clinton Bybee
Ownership Network Relation of Clinton Bybee
![Insider Network Chart](https://static.gurufocus.com/insider-network.png)
Clinton Bybee Owned Company Details
What does Codiak BioSciences Inc do?
Who are the key executives at Codiak BioSciences Inc?
Clinton Bybee is the 10 percent owner of Codiak BioSciences Inc. Other key executives at Codiak BioSciences Inc include See Remarks Yalonda Howze , Chief Scientific Officer Sriram Sathyanarayanan , and See Remarks Nicole Barna .
Codiak BioSciences Inc (CDAKQ) Insider Trades Summary
Over the past 18 months, Clinton Bybee made no insider transaction in Codiak BioSciences Inc (CDAKQ). Other recent insider transactions involving Codiak BioSciences Inc (CDAKQ) include a net sale of 41,667 shares made by Douglas E Williams , a net sale of 13,412 shares made by Linda Bain , and a net sale of 11,762 shares made by Sriram Sathyanarayanan .
In summary, during the past 3 months, insiders sold 0 shares of Codiak BioSciences Inc (CDAKQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 85,138 shares of Codiak BioSciences Inc (CDAKQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 85,138 shares.
Codiak BioSciences Inc (CDAKQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Codiak BioSciences Inc Insider Transactions
Clinton Bybee Mailing Address
Above is the net worth, insider trading, and ownership report for Clinton Bybee. You might contact Clinton Bybee via mailing address: 8755 W. Higgins Road, Suite 1025, Chicago Il 60631.